Panagora Asset Management Inc Ideaya Biosciences, Inc. Transaction History

Panagora Asset Management Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$8.28 - $13.88 $4,421 - $7,411	-534 Reduced 2.14%	24,372 $336,000
Q4 2021 Feb 10, 2022	BUY	$20.95 - $26.88 $6,180 - $7,929	295 Added 1.2%	24,906 $589,000
Q3 2021 Nov 10, 2021	BUY	$17.26 - $27.08 $414,170 - $649,811	23,996 Added 3901.79%	24,611 $627,000
Q2 2021 Aug 11, 2021	SELL	$17.76 - $24.83 $19,820 - $27,710	-1,116 Reduced 64.47%	615 $13,000
Q1 2021 May 12, 2021	BUY	$13.48 - $23.77 $14,598 - $25,742	1,083 Added 167.13%	1,731 $41,000
Q4 2020 Feb 10, 2021	SELL	$12.17 - $17.52 $56,639 - $81,538	-4,654 Reduced 87.78%	648 $9,000
Q3 2020 Nov 13, 2020	BUY	$11.22 - $14.46 $19,971 - $25,738	1,780 Added 50.54%	5,302 $67,000
Q2 2020 Aug 12, 2020	BUY	$3.59 - $18.57 $12,069 - $62,432	3,362 Added 2101.25%	3,522 $50,000
Q4 2019 Feb 12, 2020	BUY	$5.34 - $9.09 $854 - $1,454	160 New	160 $1,000

213

81M

69K

20K

Ticker IDYA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,067,700
Market Cap $1.15B
Description
IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Panagora Asset Management Inc with notifications on news.